Dennis Slamon - 18 Mar 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
18 Mar 2024
Net transactions value
-$33.1
Form type
4
Filing time
20 Mar 2024, 17:13:32 UTC
Previous filing
24 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $797,000 +10,000 +32% $79.70 40,809 18 Mar 2024 Direct
transaction BMRN Common Stock Tax liability $797,033 -9,510 -23% $83.81 31,299 18 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Options Exercise $0 -10,000 -100% $0.000000* 0 18 Mar 2024 Common Stock 10,000 $79.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of options outstanding after the transaction from this specific stock option grant.